# Patient selection and management for successful cementless total knee arthroplasty

**Authors:** Byung Sun Choi, Min Jung, Byung Woo Cho, Jun Young Chung, Jeong Ku Ha, Hyuk-Soo Han

PMC · DOI: 10.1186/s43019-026-00300-0 · Knee Surgery & Related Research · 2026-01-22

## TL;DR

This paper discusses how selecting the right patients and using modern cementless implants can lead to successful knee replacement surgery, especially for younger and active individuals.

## Contribution

The paper highlights the renewed interest in cementless TKA and emphasizes the importance of patient selection and advances in implant design for improved outcomes.

## Key findings

- Cementless TKA is a viable alternative to cemented fixation, especially for younger and active patients.
- Advances in implant design have improved clinical outcomes and biological fixation in cementless TKA.
- Pharmacologic interventions may enhance bone density and implant fixation in cementless TKA.

## Abstract

Total knee arthroplasty (TKA) is a widely performed procedure for end-stage arthritis, with cemented fixation historically dominating owing to its immediate stability and ability to compensate for minor bone defects. However, concerns over the long-term durability of cemented implants, particularly in younger and more active patients, have renewed interest in cementless TKA as a viable alternative. Advances in implant design, including hydroxyapatite coatings and porous metal surfaces, have improved clinical outcomes, reducing early loosening and enhancing biological fixation. Proper patient selection is crucial for the success of cementless TKA. Studies suggest that younger patients, those with good bone quality, and even some elderly or obese individuals may benefit from cementless implants. While initial migration of the tibial component is more pronounced in cementless TKA, research indicates that this stabilizes over time without impacting long-term outcomes. In addition, pharmacologic interventions, such as bisphosphonates and teriparatide, may help enhance periprosthetic bone density and implant fixation. Despite promising results, challenges remain, particularly in patients with osteoporosis, rheumatoid arthritis, and smoking-related bone health issues. Further research is needed to refine selection criteria, optimize surgical techniques, and ensure long-term success. As next-generation cementless implants continue to evolve, ongoing studies will be essential in guiding patient management strategies for improved outcomes.

## Linked entities

- **Chemicals:** teriparatide (PubChem CID 16133850)
- **Diseases:** osteoporosis (MONDO:0005298), rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Diseases:** overweight (MESH:D050177), aseptic loosening (MESH:D011475), bone (MESH:D001847), varus (MESH:D060905), inflammatory (MESH:D007249), bone resorption (MESH:D001862), end-stage arthritis (MESH:D007676), pain (MESH:D010146), TKA (MESH:D007718), osteonecrosis (MESH:D010020), arthritis (MESH:D001168), tibial failure (MESH:D051437), osteoporotic (MESH:D058866), deformity (MESH:D009140), Obesity (MESH:D009765), periprosthetic fractures (MESH:D057068), infection (MESH:D007239), Osteoporosis (MESH:D010024), osteolysis (MESH:D010014), knee osteoarthritis (MESH:D020370), osteopenia (MESH:D001851), RA (MESH:D001172), vitamin D deficiency (MESH:D014808)
- **Chemicals:** teriparatide (MESH:D019379), oxygen (MESH:D010100), titanium nitride (MESH:C041500), titanium (MESH:D014025), vitamin D (MESH:D014807), bisphosphonate (MESH:D004164), HA (MESH:D017886), Nicotine (MESH:D009538), PPS (-)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12829262/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12829262/full.md

---
Source: https://tomesphere.com/paper/PMC12829262